Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries.

BACKGROUND Myocardial infarction mortality has declined since the 1970s, but contemporary drivers of this trend remain unexplained. The aim of this study was to compare the contribution of trends in event rates and case fatality to declines in myocardial infarction mortality in four high-income jurisdictions from 2002-15. METHODS Linked hospitalisation and mortality data were obtained from New South Wales (NSW), Australia; Ontario, Canada; New Zealand; and England, UK. People aged between 30 years and 105 years were included in the study. Age-adjusted trends in myocardial infarction event rates and case fatality were estimated from Poisson and binomial regression models, and their relative contribution to trends in myocardial infarction mortality calculated. FINDINGS 1 947 895 myocardial infarction events from a population of 80·4 million people were identified in people aged 30 years or older. There were significant declines in myocardial infarction mortality, event rates, and case fatality in all jurisdictions. Age-standardised myocardial infarction event rates were highest in New Zealand (men 893/100 000 person-years in 2002, 536/100 000 person-years in 2015; women 482/100 000 person-years in 2002, 271/100 000 person-years in 2015) and lowest in England (men 513/100 000 person-years in 2002, 382/100 000 person-years in 2015; women 238/100 000 person-years in 2002, 173/100 000 person-years in 2015). Annual age-adjusted reductions in event rates ranged from -2·6% (95% CI -3·0 to -2·3) in men in England to -4·3% (-4·4 to -4·1) in women in Ontario. Age-standardised case fatality was highest in England in 2002 (48%), but declined at a greater rate than in the other jurisdictions (men -4·1%/year, 95% CI -4·2 to -4·0%; women -4·4%/year, -4·5 to -4·3%). Declines in myocardial infarction mortality rates ranged from -6·1%/year to -7·6%/year. Event rate declines were the greater contributor to myocardial infarction mortality reductions in Ontario (69·4% for men and women), New Zealand (men 68·4%; women 67·5%), and NSW women (60·1%), whereas reductions in case fatality were the greater contributor in England (60% in men and women) and for NSW men (54%). There were greater contributions from case fatality than event rate reductions in people younger than 55 years in all jurisdictions, with contributions to mortality declines varying by country in those aged 55-74 years. Event rate declines had a greater impact than changes in case fatality in those aged 75 years and older. INTERPRETATION While the mortality burden of myocardial infarction has continued to fall across these four populations, the relative contribution of trends in myocardial infarction event rates and case fatality to declining mortality varied between jurisdictions, including by age and sex. Understanding the causes of this variation will enable optimisation of prevention and treatment efforts. FUNDING National Health and Medical Research Council, Australia; Australian Research Council; Health Research Council of New Zealand; Canadian Institutes of Health Research, Canada; National Institute for Health Research, UK.

[1]  Kenneth K C Man,et al.  Trends in lipid-modifying agent use in 83 countries , 2021, medRxiv.

[2]  Shunsuke Aoi,et al.  Coronary , 2020, Definitions.

[3]  M. Marmot,et al.  Premature mortality attributable to socioeconomic inequality in England between 2003 and 2018: an observational study , 2019, The Lancet. Public health.

[4]  Alan D. Lopez,et al.  Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics. , 2019, International journal of epidemiology.

[5]  Yannan Jiang,et al.  Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006–2016 , 2019, Heart.

[6]  M. Goldacre,et al.  Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults , 2019, BMJ.

[7]  M. Goldacre,et al.  Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia , 2019, Heart.

[8]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[9]  Jim Warren,et al.  Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study , 2018, The Lancet.

[10]  S. Gibb,et al.  Constructing whole of population cohorts for health and social research using the New Zealand Integrated Data Infrastructure , 2018, Australian and New Zealand journal of public health.

[11]  M. Goldacre,et al.  Identification of myocardial infarction type from electronic hospital data in England and Australia: a comparative data linkage study , 2017, BMJ Open.

[12]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[13]  N. Danchin,et al.  Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–14 , 2017, European heart journal.

[14]  Karey Iron,et al.  Describing the linkages of the immigration, refugees and citizenship Canada permanent resident data and vital statistics death registry to Ontario’s administrative health database , 2016, BMC Medical Informatics and Decision Making.

[15]  N. Cook,et al.  Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. , 2016, Journal of the American College of Cardiology.

[16]  Andrew E Moran,et al.  Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013 , 2015, Circulation.

[17]  P. Elliott,et al.  Contributions of risk factors and medical care to cardiovascular mortality trends , 2015, Nature Reviews Cardiology.

[18]  Veikko Salomaa,et al.  Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations , 2015, Heart.

[19]  Julie Mytton,et al.  Enabling data linkage to maximise the value of public health research data: Summary report , 2015 .

[20]  I. Ranasinghe,et al.  Long-term mortality following interhospital transfer for acute myocardial infarction , 2015, Heart.

[21]  G. Sulo,et al.  Favourable trends in incidence of AMI in Norway during 2001–2009 do not include younger adults: a CVDNOR project , 2014, European journal of preventive cardiology.

[22]  M. Bachmann,et al.  The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP). , 2014, European heart journal.

[23]  P. Heuschmann,et al.  Supplementary Appendix , 2015 .

[24]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[25]  M. Goldacre,et al.  Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study , 2012, BMJ : British Medical Journal.

[26]  I. Ranasinghe,et al.  Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007 , 2011 .

[27]  B. Yawn,et al.  Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2010, Circulation.

[28]  C. Meisinger,et al.  Extent of the Decrease of 28-Day Case Fatality of Hospitalized Patients With Acute Myocardial Infarction Over 22 Years: Epidemiological Versus Clinical View: The MONICA/KORA Augsburg Infarction Registry , 2009, Circulation. Cardiovascular quality and outcomes.

[29]  P. Whincup,et al.  How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study , 2008, Circulation.

[30]  E. Ford,et al.  Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults , 2007, Heart.

[31]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[32]  Richard J. K. Taylor,et al.  Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[33]  JohnMcMurray,et al.  Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993 , 2000 .

[34]  J. McMurray,et al.  Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993 , 2000, Circulation.

[35]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[36]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. , 1999, Lancet.